title: Multiple bone lesions resembling a metastatic origin. An unexpected diagnosis.
abstract: Lytic and blastic lesions have been associated to malignant tumours, such as solid cancer (breast cancer, renal cancer, prostate cancer, malignant melanoma or thyroid tumours). Although a mixed pattern with lytic and blastic lesions is due to metastatic tumour, this is not the only possible origin. The following case shows a systematic. This case report shows the number of tests that were made in order to discover the origin of osteolytic and osteoblastic lesions and it is notable that there is not an occult neoplasia on every occasion.
authors.affiliation: Department of Oncology, General University Hospital in Elche, Elche, Alicante, Spain. mjmolinagarrido@hotmail.com
authors.forename: M José
authors.initials: MJ
authors.lastname: Molina-Garrido
authors.forename: A
authors.initials: A
authors.lastname: Mora
authors.forename: Encarna
authors.initials: E
authors.lastname: Andrada
authors.forename: Carmen
authors.initials: C
authors.lastname: Guillén-Ponce
authors.forename: Víctor
authors.initials: V
authors.lastname: Cánovas
authors.forename: M
authors.initials: M
authors.lastname: Guirado-Risueño
authors.forename: Elisa
authors.initials: E
authors.lastname: Pastor
authors.forename: M Angeles
authors.initials: MA
authors.lastname: Molina
authors.forename: M Jesús
authors.initials: MJ
authors.lastname: Molina
authors.forename: Alberto
authors.initials: A
authors.lastname: Martín Hidalgo
authors.forename: Alfredo
authors.initials: A
authors.lastname: Carrato
mesh_terms: D000368:Aged; D000740:Anemia / Q000150:complications; D001416:Back Pain / Q000209:etiology; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary*; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D007093:Imidazoles / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D034721:Mastocytosis, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D010014:Osteolysis / Q000188:drug therapy / Q000209:etiology*; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy; D011877:Radionuclide Imaging; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D007155:Immunologic Factors; D016898:Interferon-alpha; D000077211:Zoledronic Acid